Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma

NCT02040376 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT02040376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02040376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma
Lead sponsor
The Hospital for Sick Children
Phase
Phase 3
Overall status
Completed
Start date
June 13, 2014
Completion date
December 15, 2017
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor treated with cranial or cranial-spinal radiation